Dermatan sulfate proteoglycan metabolic process

pathway activity — cross-omics
GO:0050655Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Dermatan sulfate proteoglycan metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PTPRU, COL6A2, and PGAM4, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Dermatan sulfate proteoglycan metabolic process activity versus PTPRU in LSCC (Pearson r = 0.21).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCPTPRU →+0.965+0.181<.001.00235
GBMCOL6A2 →+1.101+0.143.005.00334
COADPGAM4 →+0.235+0.133<.001.00634
LSCCCD63 →+0.503+0.192<.001<.00134
BRCATGFB1I1 →+0.732+0.143.002.00534
BRCAKCNMB1 →+0.616+0.159<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0050655 vs PTPRU — LSCC

Per-sample scatter of Dermatan sulfate proteoglycan metabolic process activity vs PTPRU in LSCC.

Explore this scatter interactively →

Exploration